Selection Against Undifferentiated Human Embryonic Stem Cells by a Cytotoxic Antibody Recognizing Podocalyxin‐Like Protein‐1

Future therapeutic applications of differentiated human embryonic stem cells (hESC) carry a risk of teratoma formation by contaminating undifferentiated hESC. We generated 10 monoclonal antibodies (mAbs) against surface antigens of undifferentiated hESC, showing strong reactivity against undifferentiated, but not differentiated hESC. The mAbs did not cross react with mouse fibroblasts and showed weak to no reactivity against human embryonal carcinoma cells. Notably, one antibody (mAb 84) is cytotoxic to undifferentiated hESC and NCCIT cells in a concentration‐dependent, complement‐independent manner. mAb 84 induced cell death of undifferentiated, but not differentiated hESC within 30 minutes of incubation, and immunoprecipitation of the mAb‐antigen complex revealed that the antigen is podocalyxin‐like protein‐1. Importantly, we observed absence of tumor formation when hESC and NCCIT cells were treated with mAb 84 prior to transplantation into severe combined immunodeficiency mice. Our data indicate that mAb 84 may be useful in eliminating residual hESC from differentiated cells populations for clinical applications.

[1]  Kwang-Soo Kim,et al.  Genetic selection of sox1GFP‐expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation , 2006, Journal of neurochemistry.

[2]  Steve Oh,et al.  Expansion of pluripotent human embryonic stem cells on human feeders , 2004, Biotechnology and bioengineering.

[3]  D. Huntsman,et al.  Overexpression of the Anti-Adhesin Podocalyxin Is an Independent Predictor of Breast Cancer Progression , 2004, Cancer Research.

[4]  Steve Oh,et al.  High density cultures of embryonic stem cells. , 2005, Biotechnology and bioengineering.

[5]  A. Lindahl,et al.  Clonal derivation and characterization of human embryonic stem cell lines. , 2006, Journal of biotechnology.

[6]  M. Farquhar,et al.  Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. , 2000, Molecular biology of the cell.

[7]  J. Gu,et al.  A cell surface receptor defined by a mAb mediates a unique type of cell death similar to oncosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Majno,et al.  Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[9]  M. Salto‐Tellez,et al.  AFP+, ESC‐Derived Cells Engraft and Differentiate into Hepatocytes in Vivo , 2002, Stem cells.

[10]  Alan Colman,et al.  Cell therapy and the safety of embryonic stem cell-derived grafts. , 2007, Trends in biotechnology.

[11]  M. Murakami,et al.  The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.

[12]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[13]  G. Freeman,et al.  Molecular cloning of Porimin, a novel cell surface receptor mediating oncotic cell death , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Mcwhir,et al.  Ablation of Undifferentiated Human Embryonic Stem Cells: Exploiting Innate Immunity Against the Gal α1‐3Galβ1‐4GlcNAc‐R (α‐Gal) Epitope , 2007 .

[15]  M. Stojkovic,et al.  Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site. , 2006, Stem cells and development.

[16]  R. Wiggins,et al.  Assignment of the human podocalyxin-like protein (PODXL) gene to 7q32-q33. , 1997, Genomics.

[17]  J. Nichols,et al.  Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.

[18]  D. Kerjaschki,et al.  Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell , 1984, The Journal of cell biology.

[19]  P. Avner,et al.  Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. , 1984, Hybridoma.

[20]  Yoshiki Sasai,et al.  Fluorescence‐Activated Cell Sorting–Based Purification of Embryonic Stem Cell–Derived Neural Precursors Averts Tumor Formation after Transplantation , 2006, Stem cells.

[21]  Ying Liu,et al.  Assessing Self‐Renewal and Differentiation in Human Embryonic Stem Cell Lines , 2006, Stem cells.

[22]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. , 1992, Biotechnology.

[23]  J. Ledbetter,et al.  Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. , 1998, Blood.

[24]  P. Andrews,et al.  A comparative study of eight cell lines derived from human testicular teratocarcinoma , 1980, International journal of cancer.

[25]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[26]  I. Khrebtukova,et al.  Transcriptome Profiling of Human and Murine ESCs Identifies Divergent Paths Required to Maintain the Stem Cell State , 2005, Stem cells.

[27]  Mahendra S Rao,et al.  Development of antibodies to human embryonic stem cell antigens , 2005, BMC Developmental Biology.

[28]  B. Lawrenz,et al.  Highly sensitive biosafety model for stem-cell-derived grafts. , 2004, Cytotherapy.

[29]  C. Leprince,et al.  B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. , 1995, Journal of immunology.

[30]  J. Thomson,et al.  Surface antigens of human embryonic stem cells: changes upon differentiation in culture * , 2002, Journal of anatomy.

[31]  T. Harkany,et al.  Region‐specific generation of functional neurons from naive embryonic stem cells in adult brain , 2004, Journal of neurochemistry.

[32]  David W. Melton,et al.  Targetted correction of a mutant HPRT gene in mouse embryonic stem cells , 1987, Nature.

[33]  K. Guegler,et al.  Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation , 2004, Nature Biotechnology.

[34]  C. Sassetti,et al.  Identification of Podocalyxin-like Protein as a High Endothelial Venule Ligand for L-selectin: Parallels to CD34 , 1998, The Journal of experimental medicine.

[35]  R. Wiggins,et al.  Molecular Cloning, Expression, and Characterization of Podocalyxin-like Protein 1 from Rabbit as a Transmembrane Protein of Glomerular Podocytes and Vascular Endothelium * , 1995, The Journal of Biological Chemistry.

[36]  A. Miyajima,et al.  Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells , 2005 .

[37]  C. Sassetti,et al.  Identification of Endoglycan, a Member of the CD34/Podocalyxin Family of Sialomucins* , 2000, The Journal of Biological Chemistry.

[38]  A. Trounson,et al.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro , 2000, Nature Biotechnology.

[39]  J. Witte,et al.  Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. , 2006, Human molecular genetics.

[40]  D. Solter,et al.  Stage‐specific embryonic antigens (SSEA‐3 and ‐4) are epitopes of a unique globo‐series ganglioside isolated from human teratocarcinoma cells. , 1983, The EMBO journal.

[41]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Philp,et al.  Large-scale gene expression analysis of cholesterol dependence in NS0 cells. , 2005, Biotechnology and bioengineering.

[43]  J. Mcwhir,et al.  Ablation of undifferentiated human embryonic stem cells: exploiting innate immunity against the Gal alpha1-3Galbeta1-4GlcNAc-R (alpha-Gal) epitope. , 2007, Stem cells.

[44]  M. Rijn,et al.  Novel endothelial cell markers in hepatocellular carcinoma , 2004, Modern Pathology.

[45]  Steve Oh,et al.  Immortalized feeders for the scale-up of human embryonic stem cells in feeder and feeder-free conditions. , 2006, Journal of biotechnology.

[46]  W. DeWolf,et al.  The TRA‐1‐60 and TRA‐1‐81 Human Pluripotent Stem Cell Markers Are Expressed on Podocalyxin in Embryonal Carcinoma , 2007, Stem cells.

[47]  M. Fanger,et al.  Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells. , 1982, Journal of immunology.